Pharmacy practitioners' views on computerized documentation of drug-related problems

Annals of Pharmacotherapy

Volumn 37, Issue 3, 2003, Pages 354-360

  Westerlund, L O Tommy ^a,b,d   Handl, Wolfgang H A ^a   Marklund, Bertil R G ^b,c   Allebeck, Peter ^b   Gutiérrez, Luz M ^e   Kaiser, Jean Marie ^e  

^a Apoteket AB   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c Research and Development Unit   (Sweden)

^d Box 1052   (Sweden)

^e Apoteket Björnen ^*

Author keywords

Computerized documentation; Drug related problems; Sweden

Indexed keywords

NON PRESCRIPTION DRUG;

ARTICLE; ATTITUDE; AUTOMATION; COMPUTER PROGRAM; COMPUTER SYSTEM; DRUG INDUCED DISEASE; DRUG UTILIZATION; EVALUATION; EXPERIENCE; HEALTH CARE QUALITY; HUMAN; LINEAR REGRESSION ANALYSIS; MEDICAL DOCUMENTATION; NORMAL HUMAN; PATIENT COUNSELING; PATIENT EDUCATION; PHARMACIST; PHARMACY; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; QUESTIONNAIRE; SELF MEDICATION; SWEDEN; WORKPLACE;

EID: 0037372973     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1C182     Document Type: Article

References (25)

1. Young D. Many consumers misuse nonprescription medicines. ASHP 25 January 2002. www.ashp.com/public/news/breaking. (accessed 2002 Jan 28).
2. Westerlund LOT, Marklund BRG, Handl WHA, Thunberg ME, Allebeck P. Nonprescription drug-related problems and pharmacy interventions. Ann Pharmacother 2001;35:1343-9.
3. Clark D, Layton D, Shakir SAW. Monitoring the safety of over the counter drugs. BMJ 2001;323:706-7.
4. Prospecting for profits in the OTC market. Proceedings of two educational sessions. Presented at: the American Pharmaceutical Association 147th Annual Meeting & Exposition, Washington, DC, March 13, 2000. APhA Highlights Newsletter 2000;3(4):1-6.
5. Communication from the Commission concerning health promotion, information, education and training within the framework for community action in the field of public health. European Commission, Brussels, Belgium, June 1. 1994.
6. Responsible self-medication. Joint statement by the International Pharmaceutical Federation (FIP) and the World Self Medication Industry (WSMI). Int Pharm J 1999;13:4.
7. Farris KB, Kirking DM. Predicting community pharmacists' choice among means to prevent and correct clinically significant drug-therapy problems. J Soc Adm Pharm 1998;15:69-82.
8. Taylor J, Berger B, Anderson-Harper H, Grimley D. Pharmacists' readiness to assess consumers' over-the-counter product selections. J Am Pharm Assoc 2000;40:487-94.
9. Odedina FT, Segal R, Hepler CD. Providing pharmaceutical care in community practice: differences between providers and non-providers of pharmaceutical care. J Soc Adm Pharm 1995;12:170-80.
10. Venkataraman K, Madhavan S, Bone P. Barriers and facilitators to pharmaceutical care in rural community practice. J Soc Adm Pharm 1997;14:208-19.
11. Bell HM, McElnay JC, Hughes CM, Woods A. A qualitative investigation of the attitudes and opinions of community pharmacists to pharmaceutical care. J Soc Adm Pharm 1998;15:284-95.
12. Westerlund T, Almarsdóttir AB, Melander A. Factors influencing the detection rate of drug-related problems in community pharmacy. Pharm World Sci 1999;21:245-50.
13. Rossing C, Holme Hansen E, Krass I. Barriers and facilitators in pharmaceutical care: perceptions and experiences among Danish community pharmacists. J Soc Adm Pharm 2001;19:55-64.
14. van Mil JWF, de Boer WO. Tromp ThFJ. European barriers to the implementation of pharmaceutical care. Int J Pharm Pract 2001;9:163-8.
15. Winslade NE, Bajcar JM, Bombassaro AM, Caravaggio CD, Strong DK, Yamashita SK. Pharmacist's management of drug-related problems: a tool for teaching and providing pharmaceutical care. Pharmacotherapy 1997;17:801-9.
16. Westerlund T, Almarsdóttir AB, Melander A. Drug-related problems and pharmacy interventions in community practice. Int J Pharm Pract 1999;7:40-50.
17. van Mil F, Schaefer M, Verheyen F, Schulz M. [Drug-related problems in community pharmacies] (German). Pharm Ztg 2001;146:1308-14.
18. Segal R. Therapeutic outcomes monitoring: a method for implementing pharmaceutical care. In: Escovitz A, Pathak DS, eds. Health outcomes and pharmaceutical care: measurement, application, and initiatives. Binghamton, NY: The Haworth Press, 1996:194.
19. van Mil F, ed. Proceedings of the International Working Conference on Outcomes Measurements in Pharmaceutical Care. Pharmaceutical Care Network Europe (PCNE). Hillerød, Denmark, January 26-29, 1999:84.
20. Westerlund T. A national pharmacy chain - pros and cons of the Swedish system. J Managed Pharmaceut Care 2001;1:83-8.
21. Marklund B [Symptom Advice Intervention], Swedish. Vȧrdutveckling AB, CW Carlssons Trycken AB, Vänersborg, Sweden, 1999.
22. Sanz F, Silveira C, Díaz C, Alonso A, Loza MI, Cordero L, et al. Information technology in community pharmacies for supporting responsible self-medication. Am J Health Syst Pharm 2000;57:1601-3.
23. Odedina FT, Segal R, Hepler CD, Lipowski E, Kimberlin C. Changing pharmacists' practice pattern: pharmacists' implementation of pharmaceutical care factors. J Soc Adm Pharm 1996;13:74-88.
24. Willison DJ, Muzzin LJ. Workload, data gathering, and quality of community pharmacists' advice. Medical Care 1995;33:29-40.
25. Sloane H, Tremble H, Ruston A, Calnan M, Lowen N. Pharmacists within the primary health care team: realising the potential. A literature review of research. The Community Pharmacy Research Consortium Study Report. The Centre for Health Services Studies, University of Kent at Canterbury, 1998-99